Targeted therapeutic strategies for the management of renal cell carcinoma - Wikidata - wikimedia - TriplyDB

Targeted therapeutic strategies for the management of renal cell carcinoma

Targeted therapeutic strategies for the management of renal cell carcinoma

http://www.wikidata.org/entity/Q27013846

about

Diverse mechanisms of AKT pathway activation in human malignancy Identification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patients Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives.Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cells.The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results.Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma Oncological and functional outcomes of salvage renal surgery following failed primary intervention for renal cell carcinoma.Ovatodiolide Targets β -Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma.ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients.Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTOR.Transition of organizational category on renal cancer.The role of surgery for metastatic renal cell carcinoma in the era of targeted therapies.Targeted therapy of kidney cancer: keeping the art around the algorithms.The VEGF pathway in lung cancer.PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection.NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma.Value of ablation therapy in the treatment of lung metastases.Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma.

P2860

Q26851604-81D87765-82D9-4A6A-9A18-220B85330E0B Q30313444-35F754D2-A1FE-4A75-9985-966A0A5EA4A1 Q34351372-611515C9-D2FC-4513-A567-4ED051913594 Q34460429-EEDDCE41-9AB2-451C-8098-C127DB8C545B Q35464515-8BC01636-F63A-4EBE-8433-DAC27A4A9699 Q35504499-288A773B-F3E9-48EB-8C3F-A897522582DF Q35550169-C6082514-C051-40C4-951F-965546DB8C64 Q36072197-2E1B0E08-F875-4699-81ED-58A7E1E82A00 Q36231927-1A562236-305A-40E0-8D3B-96C447C96213 Q36575753-5B88C738-9900-4316-AB1F-07771064CEAC Q36916021-B0FF60E7-0A56-47A6-BB79-B417051E9C7C Q37316727-1CFF1AD7-7641-4F49-A339-FCF1E527D041 Q38068584-516A8245-6D7A-4FFC-846E-AD8E7F65DA18 Q38079812-46E0C039-9917-46BD-A3DF-7CCD1A7A2426 Q38094592-0A236DC7-6C93-4047-92BC-446D3C6BE879 Q38118060-E337A02B-D573-4BBA-9A53-BE8E80EB0A79 Q38148460-C0720E42-8E23-4D90-ACB0-DAD2E3EC285C Q39143622-CB39A33D-3F03-43D2-B0D6-3A8C3C3E865A Q39154595-52A8CBDA-5CC6-4B66-9E87-9D898FD6414A Q39189579-788D766E-E62B-43C3-BF34-94C5F66CFB5F Q48200047-44A67A73-DF83-4180-98DB-7AD2291538A4 Q53179258-CC4A19E2-E31E-42C9-9E5F-D754AF8A6B95

P2860

Targeted therapeutic strategies for the management of renal cell carcinoma

http://www.wikidata.org/entity/Q27013846

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Targeted therapeutic strategies for the management of renal cell carcinoma

@ast

Targeted therapeutic strategies for the management of renal cell carcinoma

@en

Targeted therapeutic strategies for the management of renal cell carcinoma

@nl

type

label

Targeted therapeutic strategies for the management of renal cell carcinoma

@ast

Targeted therapeutic strategies for the management of renal cell carcinoma

@en

Targeted therapeutic strategies for the management of renal cell carcinoma

@nl

prefLabel

Targeted therapeutic strategies for the management of renal cell carcinoma

@ast

Targeted therapeutic strategies for the management of renal cell carcinoma

@en

Targeted therapeutic strategies for the management of renal cell carcinoma

@nl

P1433

Q27013846-5FCCC000-B0B3-4C8D-9E4E-32BC58EADA4A

P1476

Q27013846-117BE301-2DC0-41E7-9A56-64EF7197F2AD

P2093

Q27013846-00FFB8BE-5DE7-4A88-A4A9-7926D1856B26

Q27013846-D0F6A1EE-B5DA-4186-9FC7-712E021115B8

Q27013846-EC9C19F7-0A80-4466-8DC7-72B84C85B34D

P2860

Q27013846-024166D9-5F30-4C1D-ABB5-D560C297C328

Q27013846-02E8A4A9-6AC6-4C27-9A96-23FD4E22FF74

Q27013846-02FD838F-0A38-4906-B0A4-78B0A5B98B13

Q27013846-120094AC-6BE9-4E63-8ACF-3C2DFF6D451D

Q27013846-15956449-0BA4-4ED0-9EB1-E9893F18DDEB

Q27013846-16A19900-B3BA-4983-AD91-6AE0A7B2B0A2

Q27013846-17644439-EA0D-4F2E-95AC-AE6469961825

Q27013846-2293DD70-EC0D-488C-BE19-FE0582FEB26D

Q27013846-2B5361DC-38C3-4D4C-A9B9-6921FD6BC7FE

Q27013846-328913A2-EBA2-465A-B1FD-09E5E022A208

P304

Q27013846-C8F815BC-8EA4-4FA5-8DDE-3BC8DC44AD58

P31

Q27013846-A3C56635-375A-4593-B342-7645DABF78B7

P356

Q27013846-924E4947-E650-4BE4-9E97-5E3B05953F6F

P407

Q27013846-74469645-01AA-4AC7-9C1F-2AB9BDAD8BA8

P433

Q27013846-3C87A7DE-F22E-47E9-A466-6C5213BEB37A

P478

Q27013846-CD3F8EDF-6395-4BD1-8531-C21F0E613A9A

P577

Q27013846-46D5AA59-71FD-49C8-8DC8-384BC66CD42F

P5875

Q27013846-5094B9A5-1C8C-464C-A310-762E4DCCB921

P698

Q27013846-7C90353F-63C4-4D64-82A0-3EDD128C4ADF

P932

Q27013846-C5680849-8E8E-4072-A4F5-59BE85AABB64

P356

CCO.0B013E328351C646

P1433

Current Opinion in Oncology

P1476

Targeted therapeutic strategies for the management of renal cell carcinoma

@en

P2093

Eric A. Singer

http://www.w3.org/2001/XMLSchema#string

Gopal N. Gupta

http://www.w3.org/2001/XMLSchema#string

Ramaprasad Srinivasan

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Targeting the c-Met signaling pathway in cancer

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation

P304

284-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CCO.0B013E328351C646

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221840941

http://www.w3.org/2001/XMLSchema#string

P698

22343386

http://www.w3.org/2001/XMLSchema#string

P932

3471654

http://www.w3.org/2001/XMLSchema#string